Anti-IgE: Phase II data; Phase III

DNA published in The New England Journal of Medicine results of a 317-patient Phase II study showing that treatment with Anti-IgE significantly reduced asthma symptom scores after 12

Read the full 282 word article

How to gain access

Continue reading with a
two-week free trial.